Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of Yuxuebi capsule for chronic musculoskeletal pain
ChiCTR2200065835Phase 4Not yet recruiting
- Sponsor
- Shuguang Hospital
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Yuxuebi in rheumatoid arthritis (RA), knee osteoarthritis (OA), Chronic neck pain and 2 more (8 arms), sponsored by Shuguang Hospital. Primary endpoints: Global Pain Scale score, EuroQol Five Dimensions Questionnaire and 5 more. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
Yuxuebi
03
Conditions
rheumatoid arthritis (RA)knee osteoarthritis (OA)Chronic neck painLow back pain (LBP)chronic musculoskeletal pain
Beyond the preview
Go deeper on ChiCTR2200065835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065835.